Healthcare -
Biotechnology - NASDAQ - US
$ 11.17
-1.97 %
$ 552 M
Market Cap
-3.04
P/E
KALV - RESEARCH & DEVELOPMENT
Research & Development KALV - KalVista Pharmaceuticals, Inc.
86.2 M
LAST VALUE
10.82%
2 YEAR CAGR
19.73%
5 YEAR CAGR
35.18%
10 YEAR CAGR